Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Lebanon Healthcare Journal.
Press releases published on May 21, 2025
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 21, 2025
VALUE Phase III trial of EscharEx® in venous leg ulcers advancing as planned NexoBrid® manufacturing expansion on track; full operational capacity expected by year-end 2025 First quarter revenue of $4 million; full-year 2025 revenue guidance reaffirmed at …
Verona Pharma Announces June 2025 Investor Conference Participation
GlobeNewswire
·
May 21, 2025
LONDON and RALEIGH, N.C., May 21, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will participate in fireside chats at the following conferences in June 2025: Jefferies Global …
Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
May 21, 2025
VANCOUVER, British Columbia, May 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Verano to Celebrate Grand Opening of Zen Leaf Enfield, Company’s Seventh Connecticut Dispensary, Throughout Memorial Day Weekend
GlobeNewswire
·
May 21, 2025
Zen Leaf Enfield, located at 98 Elm St., adjacent to Enfield Square Mall, joins the local business community ahead of the Mall’s $250 million transformative redevelopment to “Enfield Marketplace” Verano provided funds to the Thompsonville Fire Department …
Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals
GlobeNewswire
·
May 21, 2025
PETTEN, The Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- NRG PALLAS and Curium have extended their collaboration to produce molybdenum-99 through a new multi-year agreement. Molybdenum-99, which transforms into technetium-99, is a critical isotope used in …
EuroPCR 2025: i dati più recenti dimostrano una riduzione duratura e significativa dei tassi di eventi fino a tre anni con il bioadattatore DynamX® di Elixir Medical rispetto allo stent a rilascio di farmaco
GlobeNewswire
·
May 21, 2025
Paris, May 21, 2025 (GLOBE NEWSWIRE) -- —Durata sostenuta dell’efficacia del trattamento con tassi di TLF significativamente inferiori (2,7% vs. 7,2%, p=0,030) con DynamX® rispetto al DES— —Tasso significativamente inferiore di morte cardiaca (0,5% vs. 3, …
EuroPCR 2025: Najnowsze dane potwierdzają trwały i istotnie niższy odsetek niepożądanych zdarzeń klinicznych przy zastosowaniu bioadaptatora DynamX® firmy Elixir Medical w porównaniu do stentu uwalniającego lek (DES) w okresie trzech lat
GlobeNewswire
·
May 21, 2025
Paris, May 21, 2025 (GLOBE NEWSWIRE) -- — Trwały efekt terapeutyczny z istotnie niższym współczynnikiem niepowodzeń leczenia zmiany docelowej (TLF) – 2,7% wobec 7,2% (p=0,030) dla DynamX® w porównaniu do DES — — Istotnie niższy współczynnik zgonów sercowo- …
Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership
GlobeNewswire
·
May 21, 2025
Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking strategic partnership with M42 to collaborate in drug …
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants
GlobeNewswire
·
May 21, 2025
Groundbreaking procedures extend ONWARD’s leadership in the rapidly emerging brain-computer interface (BCI) field ARC-BCI Therapy is designed to restore thought-driven movement after spinal cord injury and other movement disabilities ONWARD’s BCI …
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
GlobeNewswire
·
May 21, 2025
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary New recruit expands senior team capabilities as the business progresses its lead HDAC6 inhibitor program, AGT-100216, into the …
SYNDEO Medical Announces ISO 13485 Certification, Expanding Regulatory Portfolio and Supporting Global Growth Strategy
GlobeNewswire
·
May 21, 2025
ZAVENTEM, Belgium, May 20, 2025 (GLOBE NEWSWIRE) -- SYNDEO Medical, a Belgian-based developer of interventional procedure solutions, is pleased to announce that it has received ISO 13485 certification for its quality management system. This internationally …